Barry Moore is President of RPS and has spent decades advancing Randomization and Trial Supply Management (RTSM) across both Sponsor and Vendor organizations. He is passionate about collaboration, education, and building solutions that strengthen RTSM’s role in clinical trials. His vision is to unite professionals worldwide to enhance the field’s impact on clinical operations and, most importantly, patients.

With more than two decades of experience in biotech and pharma, Imran is a recognized leader in the RTSM (Randomization & Trial Supply Management) space. He has built and led high-performing teams, driven process innovation, and forged trusted partnerships across the clinical development ecosystem. His work is guided by a core belief: that technology and collaboration can transform how clinical trials are designed, executed, and experienced by patients.

Paul Hughes is a longtime RTSM professional currently serving as Director of Randomization and Trial Supply Management at Johnson and Johnson Innovative Medicine. Prior work experience include RTSM roles at Pfizer and ClinPhone.

Paul's focus now is to put his years as a RTSM Subject Matter Expert into effective strategy and leadership that improves the RTSM space. Paul hosts RTSM Time, a livestream on LinkedIn, in which he interviews guests and discusses topics of interest to the RTSM industry.

Paul was the first recipient of Informa's "IRT Lifetime Achievement Award" in 2024.

Derek Thornton has been a leader in the clinical supply chain and IRT industry for the last 17 years. Over the last 5 years he has led the Clinical Systems IRT team at Amgen where he drives operational excellence, clinical systems standardization, and innovation in clinical trial execution. Prior to his current role, Derek managed a department of IRT design and supply chain specialists at Almac. Derek holds a Master of Science in Oncological Sciences from the University of Utah and a Bachelor of Science in Chemistry from the University of North Carolina at Chapel Hill.

Aaron Harlett is an Executive Director at Eli Lilly and Company with responsibility for the RTSM, clinical supply systems, and analytics teams. He has over 20 years of industry experience and is excited to advance the industry and elevate RTSM professionals via RPS.

Amy Ripston has 17 years of experience in the pharmaceutical industry, including building RTSM conferences and building brands and marketing organizations. Amy is also the Founder & President of the Biospecimen Management Consortium, a non-profit dedicated to driving sample excellence in clinical research, and the CEO of Ripston Marketing Catalyst, a B2B clinical trials marketing agency.

Carol Lee is an Executive Director at Ascentage Pharma responsible for Global Clinical Supplies. With 18 years of experience working at both vendors and sponsors, she has worked to advance the adoption of technologies and build collaborative partnerships to support the advancement of clinical trials.